Manmeet Singh Soni

CIK: 0001569769

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PLSE

PULSE BIOSCIENCES, INC.

Director

SMMT

Summit Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

PLSE
PULSE BIOSCIENCES, INC.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
SMMT
Summit Therapeutics Inc.
Jun 4, 2026
Purchase(P)
Direct
25K shares at avg. $14.46$362K
SMMT
Summit Therapeutics Inc.
Jun 4, 2026
Purchase(P)
Direct
25K shares at avg. $14.43$361K
SMMT
Summit Therapeutics Inc.
Oct 21, 2025
Award(A)
Direct
53.4K shares at avg. $18.74$1000K
PLSE
PULSE BIOSCIENCES, INC.
Aug 15, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
SMMT
Summit Therapeutics Inc.
Apr 29, 2025
Award(A)
Stock Option (right to buy)
Direct
11.2M shares-
SMMT
Summit Therapeutics Inc.
Sep 11, 2024
Award(A)
Direct
44.1K shares at avg. $22.70$1000K

		Type	Shares	Price		Ownership
Jun 11, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jun 4, 2026	SMMT Summit Therapeutics Inc.	Purchase(P)	25,000	$14.46	$361,500	Direct
Jun 4, 2026	SMMT Summit Therapeutics Inc.	Purchase(P)	25,000	$14.43	$360,750	Direct
Oct 21, 2025	SMMT Summit Therapeutics Inc.	Award(A)	53,361	$18.74	$999,985	Direct
Aug 15, 2025	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Apr 29, 2025	SMMT Summit Therapeutics Inc.	Award(A) Stock Option (right to buy)	11,200,000	-	-	Direct
Sep 11, 2024	SMMT Summit Therapeutics Inc.	Award(A)	44,052	$22.70	$999,980	Direct

1-7 of 7 transactions

About Soni Manmeet Singh

Soni Manmeet Singh (SEC CIK 0001569769) files insider reports with the SEC as Director of PULSE BIOSCIENCES, INC. (PLSE) and COO and CFO of Summit Therapeutics Inc. (SMMT).

Signal8 holds 6 ownership filings by Soni Manmeet Singh, all Form 4s, filed between Sep 13, 2024 and Jun 15, 2026. Those filings report 7 transactions, from Sep 11, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Soni Manmeet Singh's filings is in MIAMI, FL.

Recent filings by Soni Manmeet Singh

Jun 11, 2026: Grant or award of PLSE derivative securities (Form 4, code A).
Jun 4, 2026: Open-market purchases of SMMT shares (2 lines, Form 4, code P).
Oct 21, 2025: Grant or award of SMMT shares (Form 4, code A).
Aug 15, 2025: Grant or award of PLSE derivative securities (Form 4, code A).
Apr 29, 2025: Grant or award of SMMT derivative securities (Form 4, code A).

Other insiders filing for PULSE BIOSCIENCES, INC. (PLSE)

Teplitsky Liane Rae, Chief Operating Officer
Skinner Jon, Chief Financial Officer
Zanganeh Mahkam, Director
van den Broek Richard, Director
DUGGAN ROBERT W, Director
Sainz Maria, Director

How to read Form 4 transaction codes